EXtension of Tablo TrEatmeNt Duration Registry

EXtension of Tablo TrEatmeNt Duration Registry (XTEND)

Observational, retrospective and prospective, multicenter, post-market study of the Tablo Hemodialysis System in hospitalized participants with End-Stage Kidney Disease or Acute Kidney Injury who are prescribed renal replacement therapy > 12 hours.

Inclusion Criteria:

• Participant weighs ≥ 34kg.
• Participant is hospitalized and has dialysis dependent End-Stage Kidney Disease or Acute Kidney Injury and is prescribed renal replacement therapy > 12 hours.

Exclusion Criteria:

• Any documented condition that the Physician feels would prevent the participant from successful inclusion in the study.